Follow the 프로젠 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 프로젠 has logged 81 reports. Market capitalisation: €106.9bn. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: 에스엘바이젠. All data is free.
79
Insider Decl.
n/a
Thresholds
€542,982
39 ops.
Buy Volume
n/a
21 ops.
Sell Volume
33Σ signal
Buys €542,982n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.